DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,401 filers reported holding DANAHER CORPORATION in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,958,974 | +1.6% | 11,843 | +1.5% | 0.76% | +0.3% |
Q1 2024 | $2,913,234 | +5.4% | 11,666 | -2.3% | 0.76% | -0.5% |
Q4 2023 | $2,762,894 | -5.2% | 11,943 | +1.6% | 0.76% | -14.2% |
Q3 2023 | $2,915,175 | -1.7% | 11,750 | -4.9% | 0.89% | +3.4% |
Q2 2023 | $2,964,960 | -6.2% | 12,354 | -1.5% | 0.86% | -6.9% |
Q1 2023 | $3,162,598 | -9.5% | 12,548 | -4.7% | 0.92% | -10.8% |
Q4 2022 | $3,496,377 | +0.4% | 13,173 | -2.4% | 1.03% | -3.5% |
Q3 2022 | $3,484,000 | -3.7% | 13,491 | -5.4% | 1.07% | +6.1% |
Q2 2022 | $3,616,000 | -15.0% | 14,262 | -1.7% | 1.01% | -5.6% |
Q1 2022 | $4,256,000 | +1.8% | 14,510 | -17.5% | 1.07% | -13.8% |
Q4 2021 | $4,181,000 | -6.8% | 17,578 | +19.3% | 1.24% | +2.5% |
Q3 2021 | $4,486,000 | +1.1% | 14,735 | -10.9% | 1.21% | -0.7% |
Q2 2021 | $4,435,000 | +14.5% | 16,529 | -4.0% | 1.22% | +12.8% |
Q1 2021 | $3,875,000 | -4.8% | 17,217 | -6.1% | 1.08% | -10.5% |
Q4 2020 | $4,071,000 | -0.3% | 18,327 | -3.3% | 1.21% | -10.0% |
Q3 2020 | $4,082,000 | +26.2% | 18,955 | +3.6% | 1.34% | +22.2% |
Q2 2020 | $3,234,000 | +13.8% | 18,291 | -10.9% | 1.10% | -2.7% |
Q1 2020 | $2,841,000 | -12.7% | 20,527 | -3.2% | 1.13% | +15.4% |
Q4 2019 | $3,253,000 | +5.9% | 21,195 | -0.4% | 0.98% | -5.1% |
Q3 2019 | $3,072,000 | -6.2% | 21,271 | -7.2% | 1.03% | -11.1% |
Q2 2019 | $3,274,000 | +5.1% | 22,909 | -2.9% | 1.16% | +3.9% |
Q1 2019 | $3,115,000 | +24.9% | 23,597 | -2.4% | 1.12% | +9.9% |
Q4 2018 | $2,494,000 | -4.0% | 24,185 | +1.2% | 1.02% | +7.2% |
Q3 2018 | $2,597,000 | +9.4% | 23,904 | -0.6% | 0.95% | +2.0% |
Q2 2018 | $2,373,000 | +0.2% | 24,040 | -0.6% | 0.93% | -1.9% |
Q1 2018 | $2,368,000 | +6.1% | 24,184 | +0.6% | 0.95% | +7.1% |
Q4 2017 | $2,231,000 | +5.8% | 24,041 | -2.2% | 0.88% | +0.7% |
Q3 2017 | $2,108,000 | +1.4% | 24,572 | -0.2% | 0.88% | -1.9% |
Q2 2017 | $2,079,000 | -2.3% | 24,631 | -0.9% | 0.89% | -6.0% |
Q1 2017 | $2,127,000 | +65.0% | 24,861 | +50.1% | 0.95% | +64.5% |
Q4 2016 | $1,289,000 | -2.5% | 16,560 | -1.8% | 0.58% | -4.8% |
Q3 2016 | $1,322,000 | -0.2% | 16,859 | +28.6% | 0.61% | -1.6% |
Q2 2016 | $1,324,000 | +7.1% | 13,105 | +0.6% | 0.62% | +4.0% |
Q1 2016 | $1,236,000 | +3.8% | 13,026 | +1.6% | 0.59% | +1.9% |
Q4 2015 | $1,191,000 | +2953.8% | 12,827 | +2465.4% | 0.58% | +6366.7% |
Q2 2014 | $39,000 | +105.3% | 500 | +100.0% | 0.01% | -10.0% |
Q1 2014 | $19,000 | 0.0% | 250 | 0.0% | 0.01% | +25.0% |
Q4 2013 | $19,000 | +11.8% | 250 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $17,000 | +6.2% | 250 | 0.0% | 0.01% | +14.3% |
Q2 2013 | $16,000 | – | 250 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |